Skip to search formSkip to main contentSkip to account menu

Type-1 Polarized Dendritic Cell-induced Antigen-specific Autologous Cytotoxic T Lymphocytes

Known as: Autologous DC1-CTL, DC1-induced Antigen-specific Autologous CTLs, Type-1 Polarized DC-induced Antigen-specific Autologous CTLs 
A preparation of autologous cytotoxic T-lymphocytes (CTL), specifically reactive to melanoma-associated antigen 3 (MAGE-3), MAGE-4, survivin, human… 
National Institutes of Health

Related topics

Related topics

4 relations
Antigen SensitizationCytotoxic T-LymphocytesT-Cell Activationimmunopotentiation

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Vaccination with liposome-coupled glypican-3-derived epitope peptide stimulates cytotoxic T lymphocytes and inhibits GPC3-expressing tumor growth in mice.
2010
2010
WT1 PEPTIDE VACCINATION IN COMBINATION WITH IMATINIB THERAPY FOR A PATIENT WITH CML IN THE CHRONIC PHASE
Although tyrosine kinase inhibitors is effective for dramatically reducing CML cells, it might be difficult to eradicate… 
2010
2010
Single-cell analysis of T-cell receptor repertoire of HTLV-1 Tax-specific cytotoxic T cells in allogeneic transplant recipients with adult T-cell leukemia/lymphoma.
Adult T-cell leukemia (ATL) is a lymphoproliferative malignancy associated with human T-cell lymphotropic virus type 1 (HTLV-1… 
2002
2002
Efficient induction of minor histocompatibility antigen HA-1-specific cytotoxic T-cells using dendritic cells retrovirally transduced with HA-1-coding cDNA.
Cytotoxic T-cells (CTLs) specific for the hematopoietic system-restricted minor histocompatibility antigen (mHag) HA-1… 
Highly Cited
1999
Highly Cited
1999
A new MAGE gene with ubiquitous expression does not code for known MAGE antigens recognized by T cells.
A number of genes of the MAGE family have been shown to code for antigens that are recognized on many human tumors by autologous… 
Highly Cited
1998
Highly Cited
1998
Anti‐MUC1 class I restricted CTLs in metastatic breast cancer patients immunized with a synthetic MUC1 peptide
Sixteen metastatic breast cancer patients were immunized with a low dose (5 μg) of a 16 amino acid MUC1 peptide (GVTSAPDTRPAPGSTA… 
1998
1998
Targeting p53 for adoptive T-cell immunotherapy.
p53 gene mutations occur in most human cancers and result in an altered protein product that accumulates within the cell… 
1998
1998
Murine Cytotoxic T Lymphocytes Recognize an Epitope in an EBNA-1 Fragment, but Fail to Lyse EBNA-1–expressing Mouse Cells
Major histocompatibility complex class I–restricted cytotoxic T lymphocytes (CTLs) specific for epitopes within eight of the nine… 
1998
1998
Characterisation of the cytotoxic alloresponse of cord blood.
As compared to bone marrow, transplantation with cord blood (CB) is associated with a lower risk of GVHD. Although some cases of… 
Review
1984
Review
1984
A molecular analysis of the cytolytic T lymphocyte response.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)